RxDoctor Payments Data

Nicholas Ketchum, MD

Physical Medicine & Rehabilitation · Milwaukee, WINPI 1801979885

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $379,638 of the $572,662 with a category attached, or 66.3%. 19 manufacturers reported payments, led by AbbVie at 42.5% of the total. Among physical medicine & rehabilitation clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$572,662in general payments, 2019–2025

Across 666 payments — averaging $859.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$243K
  • Ipsen Biopharmaceuticals, Inc$217K
  • Merz Pharmaceuticals, LLC$49K
  • Merz North America, Inc.$30K
  • Medtronic$27K
  • Saol Therapeutics Inc.$4K
  • plus $2K from 13 others
$637,002in research payments, 2019–2025

Across 402 payments — averaging $1584.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Ipsen Pharma SAS$431K
  • Merz Pharmaceuticals, LLC$169K
  • Merz North America, Inc.$21K
  • AbbVie$15K

What the payments were for

  • Consulting fees$121,13921%
  • Speaking & faculty fees$379,63866%
  • Travel & lodging$53,0369%
  • Food & beverage$18,6893%
  • Education$1600%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)270$243,142
Ipsen Biopharmaceuticals, Inc167$217,345
Merz Pharmaceuticals, LLC79$49,375
Merz North America, Inc.59$30,292
Medtronic(2 entities)56$26,814
Saol Therapeutics Inc.5$3,569
Pacira Pharmaceuticals Incorporated5$648
Microtransponder, Inc.3$385
Piramal Critical Care7$346
Amgen(2 entities)3$248
AstraZeneca1$122
MDD US Operations, LLC1$119
Revance Therapeutics, Inc.2$113
Vanda Pharmaceuticals Inc.2$41
Mallinckrodt Hospital Products Inc.2$28
Lundbeck LLC1$22
Genentech USA, Inc.1$22
Biogen1$19
Dynasplint Systems Inc.1$10

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$572,662 in reported general payments places this provider in the 95th percentile of 207 physical medicine & rehabilitation providers in Wisconsin.

See all physical medicine & rehabilitation providers in Wisconsin

Medicare billing

Part B allowed, 2024
$97,311
Medicare patients
118
Services billed
11,403

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Baclofen61$1,988
Tizanidine Hcl44$576
Gabapentin16$449
Venlafaxine Hcl ErVenlafaxine Hcl13$150
Diazepam14$42

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →